MAY 13, 2021 7:00 AM PDT

Explore Ways to Enhance Biomarker Discovery Research

By: Jessica DeWitt, Scientific Writer II

Tools and techniques for using next-generation sequencing for disease research

Discovering new biomarkers through research is the first step in precision care for cancer and other diseases. But, to find them, you often need to sequence low-input, poor-quality tissue or fluid specimens, which can present a challenge when trying to generate meaningful data. 

Integrated DNA Technologies, Inc., a US-based company known for high-quality oligos, has curated a collection of biomarker discovery resources to make the search for new biomarkers with next-generation sequencing (NGS) easier. Our NGS hub contains links to app and tech notes, white papers, interviews with researchers, webinars, articles, and more, all in one conveniently organized location. You’ll learn about innovative combinations of tools and techniques to increase the specificity and analytical sensitivity of NGS so you can characterize your target of interest.

NGS is a sequencing method that can provide valuable insight into cancer treatment and prevention. There are several approaches to using this technology for cancer research. Whole-genome sequencing provides a comprehensive view of the genetic sequence of the sample, whether it is blood, tissue, or tumor. Targeted next-generation sequencing focuses on specific areas of the genome that might be more relevant for cancer. For example, exome sequencing provides insight into protein-coding genes and is especially useful when evaluating mutation load. Hybridization capture panels can be customized to include nonprotein coding genes that might be relevant to a specific cancer like leukemia or breast cancer. NGS can include sequencing DNA or RNA. Because RNA can change the way proteins are expressed, RNA sequencing can also help researchers and clinicians learn more about cancer.

Each of these NGS techniques has a special protocol when faced with low-input or degraded samples. IDT provides tips and tricks for optimization, as well as products specifically geared toward processing low-quality samples into useable data. The ability of these methods to reveal sensitive and specific biomarkers is important since the sensitivity and specificity of biomarkers play a key role in research into targeted therapies. Minimal residual disease (MRD) is one such sensitive biomarker. MRD occurs when a small number of cancer cells remains in a patient’s blood during or after treatment; this can lead to cancer relapse. Liquid biopsy, or blood screening, paired with NGS, can detect minute numbers of cancer cells and determine whether the treatment has completely eradicated the cancer. 

Munich Leukemia Laboratory (MLL), located in Munich, Germany, works with hospitals and hematologists, as well as with pharmaceutical companies, from all over the world to research leukemia and lymphoma using cytomorphology, cytogenetics, FISH, and molecular genetics. We spoke with one of the company’s founders, Prof Dr. Torsten Haferlach, an expert in hematology and oncology, about the methods MLL uses to decrease turnaround time, increase efficiency, and provide scalable solutions for research. “I can’t even think about a time where we didn’t use NGS for molecular investigations,” says Dr. Haferlach, “We rely on IDT quality.”

Whether you download a white paper or purchase a targeted NGS panel, we are confident that IDT’s NGS hub will be a helpful addition to your cancer research support. 

About the Sponsor
Integrated DNA Technologies, Inc. (IDT) is in the business of moving science forward. We are scientists working for scientists. Our innovative tools and solutions for genomics applications are breaking down barriers and inspiring you to dream big and achieve your next breakthroughs.
You May Also Like
JUN 25, 2022
Immunology
A Link Between Hair Growth and the Immune System is Revealed
JUN 25, 2022
A Link Between Hair Growth and the Immune System is Revealed
Salk Institute researchers studying alopecia have learned more about the link between immunity and hair growth.
JUN 27, 2022
Cancer
A Genomic Scan Detects Cancer-Driving Mutations
JUN 27, 2022
A Genomic Scan Detects Cancer-Driving Mutations
Cancer develops when the DNA in our cells becomes altered, resulting in a gene mutation.  DNA alterations can occur ...
AUG 14, 2022
Immunology
After Transplant, Another Person is Cured of HIV
AUG 14, 2022
After Transplant, Another Person is Cured of HIV
For the second time this year and only the fourth time ever, researchers have announced that a person has been cured of ...
SEP 06, 2022
Genetics & Genomics
Reduced A-to-I Editing in RNA Linked to Autoimmune Disorder Risk
SEP 06, 2022
Reduced A-to-I Editing in RNA Linked to Autoimmune Disorder Risk
The genome contains the sequences for protein-coding genes, but before those seuquences are translated into protein, the ...
SEP 16, 2022
Coronavirus
Persistent COVID Cases Seem to Encourage Viral Mutations
SEP 16, 2022
Persistent COVID Cases Seem to Encourage Viral Mutations
The majority of SARS-CoV-2 infections start to get better within several days, although infected people can shed virus a ...
SEP 25, 2022
Genetics & Genomics
The next generation of library preparation solutions for DNA sequencing
SEP 25, 2022
The next generation of library preparation solutions for DNA sequencing
The next generation of library preparation solutions for DNA sequencing  Since the completion of the Human Genome P ...
Loading Comments...